C Block - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C Block

Showing results (611-620 of 613) with videos related to

Pageof 62

Sort By:

You have reached the last page of results.This site can display upto 613 results.

ESMO Open|January 20, 2026

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancerF Lynce, C Valenza, S M Niman, et al.

Ebiomedicine|April 22, 2023

The association between genetically elevated polyunsaturated fatty acids and risk of cancerPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.

Nature Communications|May 15, 2026

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trialAna C Garrido-Castro, Noah Graham, Katelyn X Li, et al.

Pageof 62

Search research articles

Showing results (611-620 of 613) with videos related to

Sort By:

Pageof 62

You have reached the last page of results.This site can display upto 613 results.

ESMO Open|January 20, 2026

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancerF Lynce, C Valenza, S M Niman, et al.

Ebiomedicine|April 22, 2023

The association between genetically elevated polyunsaturated fatty acids and risk of cancerPhilip C Haycock, Maria Carolina Borges, Kimberley Burrows, et al.

Nature Communications|May 15, 2026

Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trialAna C Garrido-Castro, Noah Graham, Katelyn X Li, et al.

Pageof 62